Is inflammation, swelling, and tenderness of the sternoclavicular joint classified as costochondritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Sternoclavicular Joint Inflammation Called Costochondritis?

No, inflammation of the sternoclavicular (claviculosternal) joint is NOT classified as costochondritis and should be recognized as a distinct clinical entity. 1

Anatomical Definition and Clinical Distinction

The American Heart Association and American College of Cardiology explicitly define costochondritis as inflammation confined to:

  • Costochondral junctions (where ribs meet costal cartilage)
  • Chondrosternal joints (where costal cartilages meet the sternum)
  • The sternoclavicular joint is specifically excluded from this definition 1

Mislabeling sternoclavicular joint inflammation as costochondritis may lead to missed diagnoses of serious underlying conditions that require different diagnostic workup and management strategies. 2

Why This Distinction Matters for Patient Outcomes

Different Disease Spectrum

When a patient presents with sternoclavicular joint swelling, tenderness, and inflammation, you must consider a broader and more serious differential diagnosis including:

  • Spondyloarthritis – bone scintigraphy shows 100% sensitivity for detecting sternoclavicular joint inflammation in anterior chest wall pain, making this joint a key early indicator 2
  • SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis) – CT findings show sclerosis in 77.3%, erosions in 44%, and hyperostosis in 41% of affected patients 2
  • Septic arthritis – requires urgent antimicrobial therapy and possible surgical drainage 2
  • Rheumatoid arthritis 2
  • Neoplastic processes 2
  • Sternocostoclavicular hyperostosis – a chronic inflammatory disorder causing sterile osteomyelitis of the sternum and medial clavicle, often associated with palmoplantar pustulosis 3

Diagnostic Approach for Sternoclavicular Joint Pathology

Initial imaging strategy:

  • Bone scintigraphy demonstrates 100% sensitivity for detecting sternoclavicular joint inflammation and is highly valuable for early identification of spondyloarthritis-related involvement 2
  • CT of the sternoclavicular region provides objective criteria showing characteristic osseous changes (sclerosis, erosions, hyperostosis) particularly useful for diagnosing SAPHO syndrome 2
  • Plain radiographs may show symmetric hyperostosis of the sternal portions of the clavicles, synostosis of the sternoclavicular joints, and thickened sternum 4

Clinical evaluation should localize tenderness precisely:

  • Sternoclavicular joint pathology presents with tenderness and possible swelling at the clavicle-sternum articulation 1
  • This is anatomically distinct from costochondritis, which shows tenderness at costochondral or chondrosternal junctions (most commonly ribs 2-7) 1

Common Pitfall to Avoid

Do not assume sternoclavicular joint inflammation is benign musculoskeletal pain. The European consensus on chronic non-bacterial osteitis (2025) lists Tietze syndrome as a separate differential diagnosis from sternoclavicular pathology, reinforcing the need to treat these entities independently. 2 Greater awareness is needed because low recognition of sternoclavicular pathology leads to diagnostic delays, resulting in significant morbidity, psychological burden, restricted mobility, and secondary degenerative joint changes. 3

Treatment Implications

Unlike costochondritis (which responds to NSAIDs, ice/heat, and reassurance 5, 6), sternoclavicular joint inflammation may require:

  • Systemic disease-modifying therapy for spondyloarthritis or rheumatoid arthritis 2
  • Intravenous bisphosphonates or TNF-alpha inhibitors for sternocostoclavicular hyperostosis 3
  • Antimicrobial therapy and surgical debridement for infectious causes 7
  • Antituberculous therapy for tubercular involvement 8

The standard costochondritis treatment approach (NSAIDs for 1-2 weeks, local ice/heat, low-dose colchicine for refractory cases) is insufficient for sternoclavicular joint pathology. 5

References

Guideline

Anatomical Definitions and Clinical Distinctions of Anterior Chest‑Wall Pain Syndromes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Costochondritis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Sternocostoclavicular hyperostosis: a review.

Therapeutic advances in musculoskeletal disease, 2011

Research

Sternocostoclavicular hyperostosis. A case report and review of the literature.

Clinical orthopaedics and related research, 1985

Guideline

Costochondritis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Costochondritis: diagnosis and treatment.

American family physician, 2009

Related Questions

Is inflammation of the claviculosternal articulation classified as costochondritis?
What causes costochondritis?
What are the causes of costochondritis in a patient with a history of trauma, physical activity, or pre-existing conditions such as arthritis or fibromyalgia?
What is the diagnosis and treatment for a patient with costochondritis?
What is the likely diagnosis and management for a patient with sharp pleuritic chest pain below the left nipple radiating to the back, a normal electrocardiogram, and unchanged calcified infrahilar nodes on chest X‑ray?
What is the most likely diagnosis and appropriate work‑up for a patient with leukopenia, mild normocytic‑to‑microcytic anemia, low hemoglobin and hematocrit, normal mean corpuscular volume, and elevated red‑cell distribution width?
How should I manage the gastroenterology and nephrology care for an adult with stage IV colon adenocarcinoma and peritoneal carcinomatosis, post‑CAPOX (capecitabine plus oxaliplatin) and exploratory laparotomy with sigmoidectomy and ileal resection, now presenting with fever, marked jaundice, leukocytosis, hyponatremia, AKI (acute kidney injury) and large multiloculated adnexal masses, to differentiate obstructive jaundice from tumor progression?
What are the side effects, contraindications, and warning signs associated with Yaz (drospirenone/ethinyl estradiol) combined oral contraceptive?
Which medications are serotonin‑norepinephrine reuptake inhibitors (SNRIs) and what are their typical adult dosing regimens?
How can I rule out streptococcal pharyngitis?
What is the definition of biochemical relapse (a rise in tumor‑specific biomarker such as prostate‑specific antigen) in oncology?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.